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Previously, we showed that hypoxia induces ligand-independent estrogen receptor (ER)a activation.
In this study, we found that hypoxia activated the ERb-mediated transcriptional response in HEK293
cells in the absence of estrogen. ERb transactivation was induced by the expression of the hypoxia-
inducible factor 1a (HIF-1a) under normoxia. ERb interacted with HIF-1a, and SRC1 and CBP poten-
tiated the effect of HIF-1a on ERb-mediated transcription. We then examined the effect of ERb on
HIF1-a transactivation. Surprisingly, ERb attenuated the transcriptional activity of HIF-1a, as mea-
sured by HRE-driven reporter gene expression and hypoxic induction of VEGF mRNA in HEK293
cells. Taken together, these data show that HIF-1a activates ERb-mediated transcription in the
absence of a ligand, and ERb inhibits HIF-1a-mediated transcription.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Estrogen and its receptors, estrogen receptor a (ERa) and b
(ERb), play an important role in many non-reproductive tissues,
including the immune, cardiovascular, and central nervous sys-
tems, as well as in normal and malignant reproductive tissues,
such as the breast, ovary, and uterus.
ERb has different biological functions than ERa, as well as sim-
ilar activities [1,2]. Ström et al. reported that in contrast to ERa,
which is an activator of cancer cell growth, ERb inhibits cancer cell
proliferation through the modulation of key regulators in the cell
cycle [3,4]. In addition, ERb can modulate the function of ERa itself.
ERb regulates ERa-mediated transcriptional activation by altering
the recruitment of c-Fos and c-Jun to estrogen-responsive promot-
ers [5]. ERb expression attenuates the growth-promoting activity
of ERa [6]. The activity of the phytoestrogen genistein can be
modulated by the proportion of the ER subtypes [7]. Microarray
analyses have shown that unoccupied ERb both stimulated and
suppressed many genes regulated by E2-occupied ERa [6]. Chang
et al. also showed a unique set of genes responsive to E2-occupied
ERb, but not ERa [6]. We investigated the modulating mechanisms
of ERb transactivation to better understand various estrogen-regu-
lated biological effects on normal tissues, as well as malignant
tumors.chemical Societies. Published by E
oo.co.kr (Y. Lee).Hypoxia is deﬁned as a state of reduced oxygen pressure in
tissues and is associated with cancer and cardiovascular disease.
Hypoxia regulates many cellular processes, such as angiogenesis,
anaerobic metabolism, cell proliferation/survival, and promotion
of metastasis, by controlling the gene expression of the major
oxygen homeostasis regulator, hypoxia inducible factor-1 (HIF-1).
HIF-1 is composed of a heterodimer pair with an oxygen-degraded
HIF-1a subunit and a constitutively expressed HIF-1b subunit
(ARNT) [8]. Under hypoxic conditions, HIF-1a is stabilized and
regulates transcription by binding to the hypoxia response element
(HRE) on target genes [9]. HIF-1a-mediated activation of transcrip-
tion requires the recruitment of coactivators, such as CBP/p300,
and factors belonging to the p160/SRC1 family of proteins
[10–13]. Ruas et al. reported that CBP plays an important role as
a mediator, and SRC-1 may recruit other cofactors of the HIF-
1a/Arnt/CBP/SRC1 complex [14].
The cross-talk between estrogen and hypoxic signaling path-
ways in breast cancer and the role of HIF-1a in estrogen receptor
signaling has attracted increased interest. It has been suggested
that hypoxia plays a key role in the development of acquired hor-
mone resistance in breast cancer by modulating the estrogen
receptor level [15]. Seifeddine et al. showed that 31 genes were
regulated by simultaneous hypoxia and E2 treatment in T47 human
breast cancer cells [16]. Estrogens stabilize and activate HIF-1a by
phosphorylation through the PI3K pathway in the uterus and ovar-
ian carcinoma cells [17,18]. Previously, we showed that hypoxia,
via HIF-1a, regulates the expression and transcriptional activationlsevier B.V. All rights reserved.
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However, the effect of hypoxia on the activation of ERb is not yet
known. This study focuses on whether hypoxia regulates ERb-
mediated transcription and whether ERb is involved in the tran-
scriptional response to hypoxia. We show that hypoxia induces
HIF-1a activated ERb-mediated transcription in the absence of a
ligand, and ERb signiﬁcantly decreases the transcriptional activity
of HIF-1a and hypoxic induction of vascular endothelial growth
factor (VEGF) mRNA in HEK293 cells.2. Materials and methods
2.1. Reagents
E2 was purchased from Sigma (St. Louis, MO, USA) and dissolved
in 100% ethanol. ICI 182,780 (ICI) was obtained from ZENECA Phar-
maceuticals (Tocris, UK). MG132, PD98059, or wortmannin (Sigma)
was dissolved in dimethyl sulfoxide (DMSO). All of the compounds
were added to the medium such that the total solvent concentra-
tion was never higher than 0.1%. An untreated group served as a
control.
2.2. Cell culture and hypoxic conditions
MCF-7 and HEK293 cells were maintained in phenol red-free
Dulbecco’s modiﬁed Eagle medium (DMEM) supplemented with
10% fetal bovine serum (FBS) (WelGENE). Cells were grown at
37 C in a humidiﬁed atmosphere of 95% air/5% CO2 and fed every
2–3 days. Before treatment, the cells were washed with phosphate-
buffered saline (PBS) and cultured in DMEM/5% charcoal–dextran
stripped FBS (CD-FBS) for 2 days to eliminate any estrogenic source
before treatment. All treatments were done with DMEM/5% CD-
FBS. We used 10 nM E2, unless otherwise noted. For the hypoxic
condition, cells were incubated at a CO2 level of 5% with 1% O2 bal-
anced with N2 using a hypoxic chamber (Forma).
2.3. Plasmids
The ERE-tk81-Luc plasmid, constructed by inserting the frag-
ment of the herpes simplex thymidine kinase promoter and two
copies of the vitellogenin ERE into pA3-luc (ERE-Luc) [21], was a
gift from Dr. Larry Jameson (Northwestern University, USA). The
pcDNA3.1-hERa plasmid was constructed by inserting the frag-
ment of the full-length hERa into pcDNA3.1 (Invitrogen). The hERb
expression vector was kindly provided by Dr. Soo-Jong Um (Sejong
University, Korea). The hypoxia responsive element (HRE)-Luc re-
porter plasmid contains four copies of the erythropoietin HRE,
the SV40 promoter, and the luciferase gene.GFP-HIF-1a vector
was kindly provided by Dr. Kyu-Won Kim (Seoul National
University, Korea). The pGAL4-Luc plasmid was a gift from Dr.
Benita Katzenellenbogen (University of Illinois, USA). The pGAL4-
HIF-1a was kindly provided by Dr. Hyun-Sung Park (Seoul Univer-
sity, Korea).
2.4. Transient transfection and luciferase assay
HEK 293 cells were transiently transfected with plasmids by
using the polyethylenimine (PEI; Polysciences) method. Lucifer-
ase activity was determined 24 or 48 h after treatment with an
AutoLumat LB953 luminometer using the luciferase assay system
(Promega Corp., Madison, WI, USA) and expressed as relative
light units. The means and standard errors of three replicates
are shown for the representative experiments. All transfection
experiments were repeated three or more times with similar
results.2.5. Reverse transcription (RT)-PCR
Total RNA was extracted using Trizol Reagent according to the
manufacturer’s instruction. RNA pellets were dissolved in diethyl-
pyrocarbonate-treated water. The yield of RNA was quantiﬁed by
spectroscopy at 260 nm. Samples were aliquoted and stored at
80 C until further processing. To synthesize ﬁrst strand cDNA,
3 lg total RNA was incubated at 70 C for 5 min with 0.5 lg of ran-
dom hexamer and deionized water (up to 11 ll). The reverse tran-
scription reaction was performed using 40 units of M-MLV reverse
transcriptase (Promega) in 5 reaction buffer (250 mmol/l Tris–
HCl; pH 8.3, 375 mM KCl, 15 mMMgCl2, 50 mM DTT), RNase inhib-
itor at 1 unit/ll, and 1 mM dNTP mixtures at 37 C for 60 min. The
reaction was terminated by heating at 70 C for 10 min, followed
by cooling at 4 C. The resulting cDNA was added to the PCR reac-
tion mixture containing 10 PCR buffer (100 mM Tris–HCl, pH 8.3,
500 mM KCl, 15 mM MgCl2), 25 units of rTaq polymerase (TakaRa,
Shiga, Japan), 4 ll of 2.5 mM dNTP mixtures, and 10 pmol of prim-
ers each. The ﬁnal volume was 50 ll. Samples were ampliﬁed at
94 C for 5 min, 23 cycles of 94 C for 45 s, 55 C for 45 s, and
72 C for 45 s using Mastercycler gradient (Eppendorf, Hamburg,
Germany). b-Actin was ampliﬁed for 20 cycles, followed by 72 C
for 5 min. The primers used were: b-actin sense primer, 50-CCTGA-
CCCTGAAGTACCCCA-30, b-actin antisense primer, 50-CGTCATG-
CAGCTCATAGCTC-30; VEGF sense primer, 50-ATGAACTTTCTGCTCT-
CTGG-30, VEGF antisense primer, 50-TCATCTCTCCTATGTGCTGGC-30.
2.6. Statistical analysis
Values shown represent the mean ± S.D. Statistical analysis was
performed by Student’s t-test, and a P-value < 0.05 was considered
signiﬁcant.3. Results
3.1. Effects of hypoxia on ERb-mediated transcription in HEK293 cells
To determine whether hypoxia activates ERb-mediated tran-
scription, HEK293 cells were transfected with plasmids containing
an ERb expression vector and an ERE-driven reporter. After trans-
fection, cells were exposed to normoxia or hypoxia, as indicated.
As a control, we conﬁrmed that hypoxia signiﬁcantly increases
the HIF-1a-dependent transcriptional activation of the HRE-driven
reporter gene in HEK293 cells (data not shown). Hypoxia activated
ERE-driven luciferase expression in cells expressing ERb (Fig. 1A),
and this hypoxic induction was blocked by the ER antagonist ICI
(Fig. 1B), indicating that hypoxia activates ERb-mediated transcrip-
tion. However, hypoxia-activated, ERb-mediated luciferase expres-
sion was not further enhanced by E2 treatment (Fig. 1A). The
difference in efﬁciency between data reported in Fig. 1A and B
may depend on the lot of plasmid preparation, the incubation time,
and the person, etc. However, we consistently observed activation
of ERE-driven luciferase expression by ERb under hypoxia.
To determine whether HIF-1a activates ERb-mediated tran-
scription, we transfected HEK293 cells with an ERE-driven reporter
plasmid and an expression vector for ERbwith or without GFP-HIF-
1a, which is stable and stimulates transcription of its target genes
under normoxic conditions [22]. As shown in Fig. 1C, HIF-1a in-
creased ERb-mediated luciferase expression approximately ﬁve-
fold. However, this induction was blocked by the addition of ICI
(Fig. 1C). These results indicate that the hypoxia-induced ERb
transactivation is mediated by HIF-1a.
CBP participates in unliganded ERb coactivation [23]. SRC1 acti-
vates ERb-mediated transcription in the absence of a ligand [23].
SRC1 and CBP act synergistically to enhance HIF-1a-dependent
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Fig. 1. Effects of hypoxia on ERb-mediated transcription in HEK293 cells. (A) Cells were transfected with an ERE-Luc reporter construct with the expression vector for hERb,
using the PEI method. At 24 h post-transfection, cells were left untreated or treated with 1 lM ICI (B) or 10 nM E2 (A) and incubated for 24 h under normoxic or hypoxic
conditions. The cells were exposed to medium conditioned by hypoxic cells (Hypoxia) or normoxic cells (con) for 24 h. After incubation, the cells were lysed and luciferase
expression was determined. Values represent the mean ± S.E.M. (N = 3). *P < 0.05. (C) HEK293 cells were transfected with an ERE-Luc reporter construct and the expression
vector for ERbwith or without the expression vector for hHIF-1a, using the PEI method. The cells were incubated with or without 1 lM ICI for 24 h. After incubation, the cells
were lysed and luciferase expression was determined. Values represent the mean ± S.D. (N = 3). *P < 0.05. All experiments were repeated at least three times. (D) HEK293 cells
were transfected with ERE-Luc and hERb, along with 0.2 lg each of hHIF-1a expression plasmid in combination with SRC1 or CBP, using the PEI method. At 48 h post-
transfection, luciferase activity was determined. Values represent the mean ± S.D. (N = 3). (Signiﬁcance compared with control *P < 0.05; signiﬁcance compared with HIF-1a
P < 0.05.) All experiments were repeated at least three times.
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coactivators on the activity of the ERE reporter. SRC1 and CBP in-
duced a moderate increase (approximately twofold) in ERb-medi-
ated luciferase expression in the absence of a ligand (data not
shown). Next, we analyzed the ability of CBP and SRC1 to enhance
the transactivation function of HIF-1a on ERb-mediated transcrip-
tion in transient transfection experiments. As shown in Fig. 1D,
SRC-1 and CBP signiﬁcantly enhanced HIF-1a-dependent tran-
scriptional activation of the ERE-driven reporter gene in HEK293
cells. These observations indicate that SRC1 and CBP can potentiate
the effect of HIF-1a on ERb-mediated transcription.
3.2. Interaction between ERb and HIF-1a
We previously reported that HIF-1a interacts with ERa [19,20].
To determine whether HIF-1a interacts with ERb as well, we car-
ried out mammalian one-hybrid assays, using full-length HIF-1a
fused to the GAL4 DBD domain, in conjunction with the GAL4-
Luc construct. HEK293 cells transfected with GAL4-HIF-1a, GAL4-
Luc, and ERb increased transactivation about fourfold compared
to cells transfected only with GAL4-HIF-1a and GAL4-Luc
(Fig. 2A). We used a hybrid of the HIF-1a N-terminus and the
VP16 transactivation domain [19] to investigate the HIF-1a-N-ter-
minus-mediated interaction. The transfection of cells expressing
ERb with HIF-1a/VP16 increased transactivation about threefold
over that of cells transfected with ERb and VP16 (Fig. 2B). Collec-tively, these results indicate that the ERb interacts with the N-ter-
minus of HIF-1a.
3.3. ERb decreases HIF-1a mediated transcription and expression of
VEGF in HEK293 cells
The effect of HIF-1a or hypoxia on ERb-mediated transcription
and the interaction between HIF-1a and ERb raised the possibility
that ERb might directly regulate HIF-1a-mediated gene transcrip-
tion. As expected, HRE-driven luciferase reporter was activated
by GFP-HIF-1a overexpression (Fig. 3A). However, to our surprise,
the mere expression of ERb in HEK293 cells signiﬁcantly decreased
the transcriptional activity of HIF-1a (Fig. 3A). We next examined
whether overexpression of ERb was capable of suppressing endog-
enous hypoxic-responsive VEGF expression. As shown in Fig. 3B,
hypoxia increased VEGF mRNA in HEK293 cells. This hypoxic
induction of VEGF mRNA was signiﬁcantly blocked by the overex-
pression of ERb. These results indicate that ERb inhibits hypoxic
induction of VEGF mRNA through the modulation of HIF-1a tran-
scriptional activity in HEK293 cells.4. Discussion
We previously showed that hypoxia activates ERa in a ligand-
independent manner, possibly through the interaction of HIF-1a
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Fig. 2. Interaction between ERb and HIF-1a. (A) HEK293 cells were transiently transfected via the PEI method with pGAL4-Luc with or without the expression vector for
GAL4-HIF-1a fusion protein, which was with or without the expression vector for hERb. At 48 h post-transfection, luciferase activity was determined. Values represent the
mean ± S.D. (N = 3). *P < 0.05. All experiments were repeated at least three times. (B) HEK293 cells were transiently transfected with ERE-Luc, hERb, and VP16 or HIF-1a/VP16
(H/V), as indicated. At 48 h post-transfection, luciferase activity was determined. Values represent the mean ± S.D. (N = 3). *P < 0.05. All experiments were repeated at least
three times.
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HIF-1a regulates ERb-mediated transcription, and ERb inﬂuences
HIF1-a activity in reverse. We found that HIF-1a activated ERb in
a ligand-independent manner, and ERb expression decreased HIF-
1a-mediated transcription and VEGF induction in HEK293 cells.
Although ERb can be activated by the same stimuli activating
ERa, ERb may play a different role in regulating transcription and
biological responses than does ERa.
In breast cancer, hypoxia can promote tumor progression by
dedifferentiation and ERa down-regulation [24,25]. Studies have
shown that estrogen induces VEGF expression in breast cancer
cells [26–29], as well as an increase in HIF-1a mRNA and protein
expression in the uterus [30]. However, several studies have sug-0
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Fig. 3. ERb decreases HIF-1a mediated transcription and expression of VEGF
in HEK293 cells. (A) HEK293 cells were transfected with HRE-Luc reporter and
hHIF-1a with or without the expression vector for hERb using the PEI method. At
48 h post-transfection, luciferase expression was determined. Values represent the
mean ± S.D. (N = 3). *P < 0.05. All experiments were repeated at least three times.
(B) HEK293 cells were transfected with hERb using the PEI method. At 24 h
post-transfection, cells were incubated for 24 h under normoxic or hypoxic
conditions. Total cellular mRNA from untransfected HEK293 cells and cells
transfected with hERb plasmids were analyzed using VEGF-speciﬁc primers, as
described in Section 2.gested that, as a negative modulator of the hypoxia-dependent
pathway, ERb inhibits angiogenesis and the growth of breast can-
cer xenografts by decreasing the expression of VEGF and PDGFB
in T47D-ERb cells [31]. Tamoxifen, which is known to activate
ERb, has been shown to inhibit the growth of breast cancer xeno-
grafts by affecting angiogenesis [32]. It has been suggested that
E2 may counteract hypoxia-induced VEGF through ERb in MDA-
MB231 cells [33]. The selective ERb agonist diarylpropiolnitrile de-
creases pulmonary artery vasoconstriction induced by hypoxia via
a nitric-oxide-dependent mechanism [34]. These ﬁndings indicate
that ERb and HIF-1amay have a unique connection, supporting our
experiments showing that ERb represses HIF-1a and is activated by
HIF-1a. The hypoxic activation of ERb may augment the tumor-
suppressing activity of ERb by inhibiting HIF-1a activation. How-
ever, this is not the case with ERa, as ERa activates HIF-1a (our
unpublished data). Studies suggest that ERb plays a dominant neg-
ative role in ERa signaling in the presence of estrogen through
competition with ERa for binding to a ligand, DNA, or cofactors
on speciﬁc promoters [35]. Our data also support the notion that
the expression of ERb inhibits HIF-1a, which could be activated
by ERa under certain circumstances. Thus, ERb may play a domi-
nant negative role in the regulation of ERa actions in response to
hypoxia by competing with ERa for binding to HIF-1a on speciﬁc
promoters, such as the VEGF gene.
SRC-1 and CBP act synergistically to enhance HIF-1a-dependent
transcription [11]. In fact, SRC1 and CBP signiﬁcantly increased the
HIF-1a-dependent transcriptional activation of the HRE-driven re-
porter gene in our system (data not shown). Thus, SRC-1 and CBP
both signiﬁcantly enhanced HIF-1a-dependent transcriptional
activation of the HRE and ERb-mediated ERE-driven reporter gene,ERE HRE
ERβ
HIF-1
ER HIF-1
ER
Fig. 4. Model illustrating the link between HIF-1a and ERb. HIF-1a activates ERb-
mediated transcription in the absence of a ligand, and ERb inhibits HIF-1a-
mediated transcription.
1318 W. Lim et al. / FEBS Letters 583 (2009) 1314–1318whether enhanced ERb transactivation by SRC1 and CBP is neces-
sary for inhibition of HIF-1a-mediated transcription is under
investigation.
In conclusion, HIF-1a activates ERb-mediated transcription in
the absence of a ligand, and ERb inhibits HIF-1a-mediated tran-
scription, as summarized in Fig. 4. Further study is required to elu-
cidate the mechanism by which HIF-1a induces ERb activation and,
in particular, to determine the physiological signiﬁcance of the
interaction between ERb and HIF-1a.
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